Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
CytomX Therapeutics, Inc. has filed 794 SEC EDGAR filings since 28 Sep 2010

SEC filing history

Showing 601-625 of 794 matching filings.

Per page
25
Current page
25
4

FORM 4

Filing date
27 Jun 2017
Reporting date
26 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-37587

CT ORDER filing

Filing date
13 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jun 2017
Reporting date
05 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jun 2017
Reporting date
31 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jun 2017
Reporting date
31 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
18 May 2017
Reporting date
15 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 May 2017
Reporting date
12 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

FORM 8-K

Filing date
15 May 2017
Reporting date
12 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37587

DEF 14A

Filing date
09 May 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
05 May 2017
Reporting date
05 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 May 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Apr 2017
Reporting date
14 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Apr 2017
Reporting date
12 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Apr 2017
Reporting date
10 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Apr 2017
Reporting date
03 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Mar 2017
Reporting date
29 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
31 Mar 2017
Reporting date
29 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .